- Home
- GDEV vs OSUR Comparison
GDEV vs OSUR Comparison
Compare GDEV & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDEV
- OSUR
- Stock Information
- Founded
- GDEV 2009
- OSUR 2000
- Country
- GDEV Cyprus
- OSUR United States
- Employees
- GDEV N/A
- OSUR N/A
- Industry
- GDEV EDP Services
- OSUR Medical/Dental Instruments
- Sector
- GDEV Technology
- OSUR Health Care
- Exchange
- GDEV Nasdaq
- OSUR Nasdaq
- Market Cap
- GDEV 266.7M
- OSUR 229.7M
- IPO Year
- GDEV N/A
- OSUR 1986
- Fundamental
- Price
- GDEV $15.76
- OSUR $3.22
- Analyst Decision
- GDEV Buy
- OSUR Hold
- Analyst Count
- GDEV 1
- OSUR 1
- Target Price
- GDEV $70.00
- OSUR $3.00
- AVG Volume (30 Days)
- GDEV 4.5K
- OSUR 607.0K
- Earning Date
- GDEV 11-13-2025
- OSUR 11-05-2025
- Dividend Yield
- GDEV N/A
- OSUR N/A
- EPS Growth
- GDEV 12.96
- OSUR N/A
- EPS
- GDEV 2.56
- OSUR N/A
- Revenue
- GDEV $425,112,000.00
- OSUR $138,533,000.00
- Revenue This Year
- GDEV N/A
- OSUR N/A
- Revenue Next Year
- GDEV $11.69
- OSUR $5.35
- P/E Ratio
- GDEV $6.35
- OSUR N/A
- Revenue Growth
- GDEV N/A
- OSUR N/A
- 52 Week Low
- GDEV $8.60
- OSUR $2.36
- 52 Week High
- GDEV $42.76
- OSUR $4.60
- Technical
- Relative Strength Index (RSI)
- GDEV 52.42
- OSUR 52.52
- Support Level
- GDEV N/A
- OSUR $3.25
- Resistance Level
- GDEV $18.17
- OSUR $3.37
- Average True Range (ATR)
- GDEV 0.80
- OSUR 0.13
- MACD
- GDEV -0.35
- OSUR -0.00
- Stochastic Oscillator
- GDEV 86.73
- OSUR 23.81
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.